HORSHAM, Pa., Oct. 03, 2025 (GLOBE NEWSWIRE) -- In recognition of Eczema Awareness Month, STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, highlights the substantial body of peer-reviewed clinical evidence supporting the XTRAC® Excimer Laser (308 nm) as a safe, highly effective treatment for localized atopic dermatitis, the most common f ...

HORSHAM, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces the publication of a new peer-reviewed study in Lasers in Medical Science that reinforces the Company’s commitment to personalized medicine. The study demonstrates that treatment using the Company’s XTRAC 308nm Excimer Laser in com ...

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - SHF Holdings, Inc. (SHFS) increased by 150% to $8.17 - Lithium Americas Corp. (LAC) rose by 69% to $5.18 - Aqua Metals, Inc. (AQMS) gained 50% reaching $6.11 - CleanCore Solutions, Inc. (ZONE) up by 44% at $2.87 - Cyclerion Therapeutics, Inc. (CYCN) increased by 33% to $4.03 - Twin Vee Powercats Co. (VEEE) rose by 17% to $2.92 - Solidion Technology, Inc. (STI) up by 11% at $5.09 - China Pharma Holdings, Inc. (CPHI) increased by 11% to $2.18 - Stardust Power Inc. (SDST) rose by 10% to $3.04 - Aligos Therapeutics, Inc. (ALGS) increased by 7% to $11.03 [3] Premarket Losers - Aytu BioPharma, Inc. (AYTU) decreased by 15% to $2.11 - Professional Diversity Network, Inc. (IPDN) down by 13% to $4.10 - STRATA Skin Sciences, Inc. (SSKN) fell by 10% to $2.31 - Cohu, Inc. (COHU) decreased by 9% to $20.68 - Super League Enterprise, Inc. (SLE) down by 9% to $7.74 - CTW Cayman (CTW) fell by 9% to $2.29 - Fitell Corporation (FTEL) decreased by 8% to $7.70 - Soluna Holdings, Inc. (SLNH) down by 8% to $2.16 - StableX Technologies, Inc. (SBLX) decreased by 5% to $5.22 - Indaptus Therapeutics, Inc. (INDP) down by 5% to $2.95 [4]

Market Overview - Recent market surge has highlighted remarkable performances from companies across diverse sectors including gaming, beverages, professional networking, data management, and medical technology [1][7] Company Performances - Super League Enterprise, Inc. (NASDAQ:SLE) saw a stock price increase of 150.91% to $8.23, driven by innovative metaverse gaming strategies and planned investments aimed at enhancing shareholder value [2][8] - Innovation Beverage Group Limited (NASDAQ:IBG) experienced a 99.97% rise in stock price to $0.73, linked to successful expansion efforts and a potential merger with BlockFuel Energy Inc. [3][8] - Professional Diversity Network, Inc. (NASDAQ:IPDN) reported a 56.64% increase in stock price to $4.48, supported by a strategic partnership with OOKC Group to create a compliance-driven Web 3.0 joint venture [4][8] - Datavault AI Inc. (NASDAQ:DVLT) rose by 54.61% to $0.63, reflecting the growing importance of data security and attracting attention with its AI offerings despite a small market cap of $53 million [5][8] - STRATA Skin Sciences, Inc. (NASDAQ:SSKN) experienced a 53.27% increase to $2.60, attributed to innovative treatments for skin conditions, particularly a combination therapy for vitiligo [6][8]

Market Overview - U.S. stocks showed mixed performance with the Dow Jones index gaining approximately 250 points on Monday, trading up 0.57% to 46,648.21 on Tuesday, while NASDAQ fell 0.33% to 22,714.37 and S&P 500 dropped 0.01% to 6,693.29 [1] - Energy shares increased by 2.2% on Tuesday, while consumer discretionary stocks decreased by 0.6% [1] Company Earnings - AutoZone, Inc. reported fourth-quarter earnings per share of $48.71, which was below the analyst consensus estimate of $50.91. Quarterly sales were $6.242 billion, reflecting a 0.6% year-over-year increase, but also missed the expected $6.245 billion [2] Commodity Market - In commodity news, oil prices rose by 1.8% to $63.41, gold increased by 1.1% to $3,816.20, silver was up 1% to $44.660, and copper rose 0.2% to $4.6400 [4] Stock Movements - Super League Enterprise, Inc. saw its shares surge 222% to $10.56 following a private placement financing announcement. Innovation Beverage Group Limited shares increased by 126% to $0.8299 after announcing a merger transaction with BlockFuel Energy. STRATA Skin Sciences, Inc. shares rose 60% to $2.7103 [8] - Conversely, Boxlight Corporation shares dropped 37% to $3.00 after pricing a $4 million offering at $3.00 per share. AtlasClear Holdings, Inc. shares fell 21% to $0.4556, and GDEV Inc. shares decreased by 20% to $25.07 [8] Economic Indicators - The S&P Global US services PMI declined to 53.9 in September from 54.5 in the previous month, while the manufacturing PMI fell to 52 from 53 in August. The U.S. current account deficit decreased by 42.9% to $251.3 billion in the second quarter [9]

Group 1: Super League Enterprise, Inc. - Super League Enterprise, Inc. announced a $10 million strategic equity investment from Evo Fund, leading to a sharp increase in its stock price [1] - Shares of Super League Enterprise rose 200% to $9.83 in pre-market trading following the announcement [1] Group 2: Other Notable Gainers - Professional Diversity Network, Inc. gained 88.8% to $5.40 in pre-market trading after a previous rise of around 4% [4] - STRATA Skin Sciences, Inc. rose 80% to $3.06 in pre-market trading after an 8% increase on Monday [4] - Jiuzi Holdings, Inc. jumped 50.9% to $1.69 in pre-market trading after a 5% gain on Monday [4] - New Era Energy & Digital, Inc. gained 47.2% to $0.8941 in pre-market trading after a surge of around 12% on Monday [4] - Better Home & Finance Holding Company increased by 30% to $64.95 in pre-market trading, following a 46% jump on Monday [4] - MicroCloud Hologram Inc. surged 29% to $7.17 in pre-market trading after announcing a breakthrough in quantum technology [4] - Cassava Sciences, Inc. rose 24.1% to $2.88 in pre-market trading after CEO Richard Barry purchased shares at an average price of $2.25 [4] - SES AI Corporation surged 10.3% to $2.04 in pre-market trading after a 17% increase on Monday [4] - Ballard Power Systems Inc. gained 8.3% to $3.12 in pre-market trading after a 5% rise on Monday [4] Group 3: Notable Decliners - Psyence Biomedical Ltd. dipped 19.6% to $3.65 in pre-market trading after a decline of around 5% on Monday [4] - Diginex Limited shares fell 17.7% to $14.60 in pre-market trading after a jump of over 30% on Monday [4] - Addentax Group Corp. declined 16.5% to $0.9021 in pre-market trading after gaining more than 30% on Monday [4] - Boxlight Corporation fell 15.5% to $4.03 in pre-market trading after a significant jump of 205% on Monday [4] - Reliance Global Group, Inc. dropped 15.5% to $0.9122 in pre-market trading after a 47% increase on Monday [4] - Qualigen Therapeutics, Inc. declined 14.1% to $4.75 in pre-market trading after a 95% jump on Monday [4] - Fly-E Group, Inc. fell 13.1% to $0.8773 in pre-market trading after announcing a securities purchase agreement [4] - Firefly Aerospace Inc. dropped 12.5% to $43.29 in pre-market trading after reporting a second-quarter loss [4] - Opendoor Technologies Inc. dipped 6.3% to $7.85 in pre-market trading after a 12% fall on Monday [4] - Symbotic Inc. fell 4.8% to $57.80 in pre-market trading after a gain of more than 6% on Monday [4]

Core Insights - STRATA Skin Sciences, Inc. has published a study confirming the superiority of its 308nm Excimer laser combined with a JAK inhibitor over monotherapy, indicating significant market growth potential and expanded treatment indications [1][2][4] Study Findings - The study involved 251 patients and demonstrated five key findings regarding the combination therapy: 1. Mechanistic synergy between JAK inhibitors and Excimer laser promoting effective treatment [6] 2. Superior efficacy with a 14.20% higher repigmentation rate compared to monotherapy [6] 3. Unprecedented response rates with a 100% significant efficacy rate after 52 weeks of treatment [6] 4. Durable stability with a 96.5% pigmentation stability rate and an 8.8% relapse rate at one-year follow-up [6] 5. Excellent safety profile with no serious or persistent adverse events reported [6] Clinical Validation - The study adds to over 400 existing studies validating the efficacy of the 308nm Excimer laser as a cornerstone therapy for various dermatologic conditions, including vitiligo and psoriasis [3][4] Market Position - STRATA's Excimer laser technology has been in use for around 20 years, and dermatologists continue to rely on its performance for durable repigmentation in challenging skin conditions [2][4] Future Directions - The company is pursuing expanded reimbursement for its treatment modalities and aims to provide broader access by early 2026 [3]

Core Insights - STRATA Skin Sciences, Inc. has highlighted a recent study demonstrating the efficacy of its 308nm Excimer laser combined with a JAK inhibitor for treating localized non-segmental vitiligo, showing superior results compared to monotherapy [1][2][4] Study Findings - The study involved 251 patients and revealed five key findings: 1. Mechanistic synergy between JAK inhibitors and Excimer laser therapy [7] 2. A 14.20% higher repigmentation rate with the combination therapy [7] 3. A 100% significant efficacy rate after 52 weeks of treatment [7] 4. At one-year follow-up, the combination group showed 96.5% pigmentation stability and an 8.8% relapse rate [7] 5. The treatment exhibited an excellent safety profile with no serious adverse events [7] Clinical Validation - The study adds to over 400 existing studies validating the 308nm Excimer laser as a cornerstone therapy for various inflammatory and autoimmune skin diseases [3][4] - The combination therapy is positioned as a personalized medicine approach, allowing for tailored treatment based on laser exposure duration and dosage [3] Company Strategy - The company is pursuing expanded reimbursement for its treatments, leveraging the strong clinical evidence from the recent study [3][4] - STRATA continues to work with regulators to enhance access to its treatment modalities by early 2026 [3]

Company Overview - STRATA Skin Sciences, Inc. is a medical technology company focused on developing and commercializing products for dermatological conditions, utilizing expertise in laser technology [1] Financial Performance - STRATA's Return on Invested Capital (ROIC) is -58.59%, while its Weighted Average Cost of Capital (WACC) is 7.71%, resulting in a ROIC to WACC ratio of -7.60, indicating inefficiencies in capital utilization [2] - Comparatively, Sensus Healthcare, Inc. has a ROIC of -4.47% and a WACC of 10.28%, leading to a ROIC to WACC ratio of -0.44, which is the highest among its peers, suggesting better capital efficiency [3] - Other peers like Soleno Therapeutics, Inc. and SenesTech, Inc. have ROIC to WACC ratios of -13.40 and -12.05, respectively, indicating significant challenges in generating returns above their cost of capital [4] - Xcel Brands, Inc. also faces issues with a ROIC to WACC ratio of -8.94, highlighting inefficiencies in capital management [4] - Overall, all companies, including STRATA, are struggling to generate returns above their cost of capital, with Sensus Healthcare standing out for its relatively better performance [5]

Core Points - STRATA Skin Sciences, Inc. has successfully closed a registered direct offering, issuing 1,097,547 shares of common stock at a price of $2.204 per share [1][2] - The gross proceeds from this offering amounted to approximately $2.42 million, which will be utilized for working capital and general corporate purposes [2] - The offering was conducted under a shelf registration statement declared effective by the SEC on December 18, 2024, with a prospectus supplement filed on September 3, 2025 [3] Company Overview - STRATA Skin Sciences is focused on developing, commercializing, and marketing innovative products for treating dermatologic conditions, including psoriasis, vitiligo, and acne [4] - The company's product lineup features the XTRAC excimer laser, VTRAC lamp systems, and the TheraClearX Acne Therapy System [4] - STRATA employs a unique Partnership Program that offers a fee per treatment cost structure, on-site training, service and maintenance, and co-op advertising support [5]